Journal
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Volume 18, Issue 12, Pages 3334-3348Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-09-0429
Keywords
-
Funding
- National Cancer Institute [HHSN261200644002]
Ask authors/readers for more resources
Tobacco products are widely sold and marketed, yet integrated data systems for identifying, tracking, and characterizing products are lacking. Tobacco manufacturers recently have developed potential reduced exposure products (PREP) with implied or explicit health claims. Currently, a systematic approach for identifying, defining, and evaluating PREPs sold at the local, state, or national levels in the United States has not been developed. Identifying, characterizing, and monitoring new tobacco products could be greatly enhanced with a responsive surveillance system. This article critically reviews available surveillance data sources for identifying and tracking tobacco products, including PREPs, evaluating strengths and weaknesses of potential data sources in light of their reliability and validity. With the absence of regulations mandating disclosure of product-specific information, it is likely that public health officials will need to rely on a variety of imperfect data sources to help identify, characterize, and monitor tobacco products, including PREPs. (Cancer Epidemiol Biomarkers Prev 2009;18(12):3334-48)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available